PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $428,000 | +678.2% | 135,953 | +700.5% | 0.01% | +1000.0% |
| Q4 2019 | $55,000 | -86.4% | 16,983 | -90.9% | 0.00% | -87.5% |
| Q3 2019 | $404,000 | -36.1% | 186,900 | -7.1% | 0.01% | -27.3% |
| Q2 2019 | $632,000 | +348.2% | 201,247 | +314.1% | 0.01% | +175.0% |
| Q4 2018 | $141,000 | -73.7% | 48,600 | -76.2% | 0.00% | -60.0% |
| Q3 2018 | $536,000 | +857.1% | 203,900 | +969.3% | 0.01% | +900.0% |
| Q1 2018 | $56,000 | -74.0% | 19,068 | -75.7% | 0.00% | -66.7% |
| Q4 2017 | $215,000 | +102.8% | 78,394 | +151.6% | 0.00% | +200.0% |
| Q3 2017 | $106,000 | +39.5% | 31,155 | +0.8% | 0.00% | 0.0% |
| Q2 2017 | $76,000 | -71.3% | 30,900 | -61.1% | 0.00% | -75.0% |
| Q1 2016 | $265,000 | +44.8% | 79,533 | +247.3% | 0.00% | -42.9% |
| Q3 2013 | $183,000 | -2.1% | 22,900 | -5.4% | 0.01% | -30.0% |
| Q2 2013 | $187,000 | – | 24,196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |